自動機械心肺蘇生装置の世界市場-2023年～2030年

概要

機械心肺蘇生（mCPR）装置は、突然の心停止（SCA）患者などに自動胸骨圧迫を行う装置です。これらの装置は、手技による心肺蘇生法のような合理的な自然循環回復（ROSC）を達成するために開発されました。しかし、手技による心肺蘇生が人為的なミスや疲労に左右されるのに対し、機械的な心肺蘇生は人為的な負担が少なく、安定した質の高い心肺蘇生を継続的に行うことができます。

そのため、手技による心肺蘇生と併用してmCPR装置を使用するケースが増えています。自動化された質の高い胸骨圧迫により、救助者は患者の状況を評価し、さらなる治療を行う時間を確保できるため、救急隊はこの技術に特にメリットを感じています。さらに、移動中の救急車内で手動CPRを行うための安全で実用的な選択肢を提供します。

市場力学：市場促進要因と市場抑制要因

心血管障害の高い有病率

心血管障害の高い有病率は、予測期間中に自動機械式心肺蘇生装置の需要を押し上げると予測されています。例えば、英国心臓協会レポート2023によると、世界では13人に1人が心臓疾患や循環器疾患を抱え、約6億2,000万人が心臓疾患や循環器疾患を抱えながら生活していると評価されており、この数はライフスタイルの変化、住民の高齢化、増加、心臓発作や脳卒中による生存率の向上により増加しており、こうした傾向が続けば今後も増加すると予測されています。

さらに2021年6月、世界保健機関（WHO）によると、2020年にCVDが原因で死亡した人の数は1,790万人と推定され、多国籍の死傷者の32％に相当します。CVDによる死亡の4分の3以上は、バングラデシュ、アフガニスタンなどの中低所得国で発生しています。2020年には、非伝染性疾患による1,700万人（70歳未満）の早期死亡者のうち、38％以上がCVDによるものです。さらに、認知度の向上、進歩、市場開拓などが、予測期間中の世界市場の成長に貢献すると予想されます。

高い機器コスト

自動機械心肺蘇生装置のコストが高いことが、予測期間中の世界市場成長の妨げになると予想されます。例えば、自動心肺蘇生装置の平均コストは10,000米ドルです。世界市場の成長を妨げるその他の要因には、熟練した専門家の不足と高い市場開拓コストが含まれます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 心血管疾患の高い有病率
  • 抑制要因
    • 高いデバイスコスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• 技術動向
• 疫学
• SWOT分析
• DMI見解

第6章 COVID-19分析

第7章 デバイスタイプ別

• ピストンデバイス
• 負荷分散デバイス
• 3Dデバイス

第8章 動力源別

• 空気圧駆動
• バッテリー駆動
• 機械駆動およびバッテリー駆動

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター（ASCs）
• 救急医療サービス（EMS）
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市場ポジショニング/シェア分析
• M&A分析

第12章 企業プロファイル

• ZOLL Medical Corporation
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Michigan Instruments
• Stryker
• CPR Medical Devices, Inc.
• Asahi Kasei Corporation
• Defibtech LLC
• Yantai Wanli Medical Equipment CO.,Ltd.
• Schiller Healthcare
• Sunlife Science
• Ambulanc（Shenzhen）Tech.Co., Ltd.

第13章 付録

Overview

Mechanical cardiopulmonary resuscitation (mCPR) devices deliver automated chest compressions to sudden cardiac arrest (SCA) sufferers and other conditions. These devices are developed to accomplish the recovery of spontaneous circulation (ROSC), reasonable such as manual CPR. Nevertheless, while manual CPR is subject to human blunder and exhaustion, mechanical CPR demands little human relations and can provide invariant high-quality CPR continuously.

Therefore, mCPR devices are increasingly being utilized in conjunction with manual CPR. EMS teams have encountered this technology specifically advantageous as the automated, high-quality chest compressions provide rescuers time to evaluate and treat further elements of the patient's situation. Further, it delivers a secure and practical option for manual CPR in a moving ambulance.

Market Dynamics: Drivers & Restraints

High Prevalence of Cardiovascular Disorders

The high prevalence of cardiovascular disorders is estimated to boost demand for automatic mechanical cardiopulmonary resuscitation devices during the forecast period. For instance, according to the British Heart Association Report 2023, worldwide it is assessed that 1 out of 13 individuals are living with a cardiac or circulatory disorder and about 620 million individuals are living with heart and circulatory diseases all over the world, this number is growing owing to altering lifestyles, an aging, and growing inhabitants, and enhanced survival rates from heart attacks and strokes and is expected to persist to advance if these tendencies persist.

Moreover, in June 2021, according to the World Health Organization, an assessed 17.9 million individuals died from CVDs in 2020, symbolizing 32% of all multinational casualties out of these deaths, over 85% were because of heart attack and stroke. More than three-quarters of CVD deaths surface in low and middle-income nations like Bangladesh, Afghanistan etc. Among the 17 million premature casualties (under the age of 70) owing to non-communicable conditions in 2020, over 38% were because of CVDs. Furthermore, growing awareness, advancements and market developments among others are expected to contribute to the global market growth during the forecast period.

High Device Cost

The high cost of automatic mechanical cardiopulmonary resuscitation devices is expected to hamper the global market growth during the forecast period. For instance, the average cost of an automated CPR device is US$ 10,000. Other factors hampering the global market growth include the deficiency of skilled professionals and high development costs.

Segment Analysis

The global automatic mechanical cardiopulmonary resuscitation devices market is segmented based on device type, power source, end user and region.

Battery-Driven CPR Devices Segment is Expected to Dominate Market

Owing to the increasing adoption of portable battery-powered automated CPR devices is expected to boost the battery-driven CPR devices market growth, dominating the global market during the forecast period. For instance, in November 2021, Horizon Health paramedics had a new, high-tech option to aid them in rescuing lives. Cardiac chest compressions that were earlier done manually, can currently be accomplished hands-free with the touch of a switch. The Horizon Health Foundation of East Central Illinois recently granted two automated CPR devices, known as AutoPulse. They are in expansion to the two AutoPulses properly in usage by the ambulance service.

Moreover, in March 2023, with a $121,835 federal grant to be used for the procurement of cardiopulmonary resuscitation (CPR) compression devices the East Haven Fire Department (EHFD) is hoping to rescue more additional lives thanks to the grant awarded via the Assistance to Firefighters Grant (AFG) program, which is part of the Federal Emergency Management Agency (FEMA). The $122,000 grant intends to supply the department with compression devices to be part of each of its unit's apparatuses that could eliminate hindrances to manually-performed CPR for those suffering from cardiac arrests and save more lives.

Geographical Analysis

North America is Expected to Dominate the Global Market

Owing to the growing cases of cardiovascular diseases, increasing efforts to raise awareness and market developments boosted the North America market growth thereby holding the majority of global market share. For instance, according to the Centers for Disease Control and Prevention, approximately 695,000 individuals in the U.S. died because of heart disorders in 2021 making up for 1 out of every 5 deaths.

Moreover, in May 2023, the American Heart Association executed the 49th Emergency Medical Services (EMS) Week, which delivered awareness to the cardiovascular patients regarding the CPR devices techniques. Furthermore, in April 2023, Defibtech, a U.S. manufacturer of life-saving medical tools, introduced the next evolution of their automated CPR device, the ARM XR. The ARM XR is planned for usage by emergency medical specialists to treat patients who are in cardiac arrest.

COVID-19 Impact Analysis:

COVID-19 has positively impacted the global automated mechanical CPR devices market as during the pandemic there was an increased need to deliver CPR to patients and a deficiency of professionals which in turn increased the demand for automated mechanical CPR devices. Moreover, increased demand and guideline constraints led to the development of advanced devices requiring minimal human interaction averting the risk of infection spread.

For instance, in March 2021, NHS Tayside-a Health Board and InnoScot Health, a healthcare corporation, united to design and create the device SARUS-CPR hood that was positioned to revolutionize the resuscitation approach for first responders. SARUS-CPR hood was adopted into clinical practice by NHS Tayside following its development in reaction to the COVID-19 pandemic.

Key Developments

• In February 2022, CPR Therapeutics Inc., a medical device company obtained a U.S. patent for another element of technology that underlies its multimodal cardiopulmonary resuscitation (CPR) system: "Incorporation of the Electrodes for Defibrillation into the Patient-Facing Components of automated Cardiopulmonary Resuscitation Systems".
• In September 2022, CPR Therapeutics Inc., a medical device company acquired a US$1.6M National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) Direct-To-Phase II Small Business Innovation Research Award for its project "A Multimodal Integrated System for Improved Cardiopulmonary Resuscitation.".

Competitive Landscape

The major global players in the market include: ZOLL Medical Corporation, Michigan Instruments, Stryker, CPR Medical Devices, Inc., Asahi Kasei Corporation, Defibtech LLC, Yantai Wanli Medical Equipment Co., Ltd., Schiller Healthcare, Ambulanc (Shenzhen) Tech.Co., Ltd. And Sunlife Science among others.

Why Purchase the Report?

• To visualize the global automatic mechanical cardiopulmonary resuscitation devices market segmentation based on device type, power source, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of automatic mechanical cardiopulmonary resuscitation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global automatic mechanical cardiopulmonary resuscitation devices market report would provide approximately 61 tables, 59 figures and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Device Type
• 3.2. Snippet by Power Source
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. High Prevalence of Cardiovascular Disorders
  • 4.1.2. Restraints
    • 4.1.2.1. High Device Cost
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. Technology Trend
• 5.8. Epidemiology
• 5.9. SWOT Analysis
• 5.10. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Device Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 7.1.2. Market Attractiveness Index, By Device Type
• 7.2. Piston Devices*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Load Distribution Devices
• 7.4. 3D Devices

8. By Power Source

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
  • 8.1.2. Market Attractiveness Index, By Power Source
• 8.2. Pneumatically Driven*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Battery Driven
• 8.4. Mechanically Actuated and Battery-Driven

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospital*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory Surgical Centers (ASCs)
• 9.5. Emergency Medical Service (EMS)
• 9.6. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. ZOLL Medical Corporation*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Michigan Instruments
• 12.3. Stryker
• 12.4. CPR Medical Devices, Inc.
• 12.5. Asahi Kasei Corporation
• 12.6. Defibtech LLC
• 12.7. Yantai Wanli Medical Equipment CO.,Ltd.
• 12.8. Schiller Healthcare
• 12.9. Sunlife Science
• 12.10. Ambulanc (Shenzhen) Tech.Co., Ltd.

LIST NOT EXHAUSTIVE.

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us